Stay updated with breaking news from David Arkowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On July 7, 2022, invoX Pharma Limited ("invoX"), a wholly owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK) commenced a cash tender offer for all of the issued and
Operator Good afternoon, ladies and gentlemen. And welcome to the Flexion Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions] We will be facilitating a question-and-answer session at the end of today's call. [Operator Instructions] I'll now turn the call over to Scott Young, Flexion's Vice President of Corporate Communications and Investor Relations. Scott Young -- Vice President of Corporate Communications & Investor Relations Good afternoon. A short while ago, we issued a press release announcing our Q1 2021 financial results. In addition, today, we a...
Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Flexion Therapeutics Inc (NASDAQ: FLXN) Popular Searches Operator Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Business Update Call. [Operator Instructions] I will now turn the call over to Scott Young, Flexion's Vice President of Corporate Communications and Investor Relations.SPONSORED: 10 stocks we like better than Flexion Therapeutics When investing geniuses David and Tom Gardner have a s...
Share: Shares of Yumanity to commence trading on Nasdaq under new ticker symbol "YMTX" on December 23, 2020 $33.6 million common stock private investment in public equity ("PIPE") transaction closes concurrently with the merger BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ:YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that its reverse merger with Proteostasis Therapeutics, Inc. closed on December 22, 2020, following the approval of...